Since the early 1970s and the demise of the Bretton-Woods agreement, economies have increasingly moved towards globalization as markets internationalize and deregulate a process that has been facilitated by the World Trade Organization (WTO), with new and historically unprecedented powers to enforce trade rules. 1 Why should the process of globalization, in general, and the rise to prominence of the WTO in particular, interest health researchers and policy makers? First, because, "owing to the health consequences, good and bad, of the sanctioning of monopoly pricing of new drugs and medical products -and because of its influence over international trade in medical supplies, insurance, and health services -the World Trade Organization is likely to emerge as one of the most important international players in health." 2, pg.193 Second, as well as the direct impact of the WTO on the trade in medical products, globalization may also impact health by creating a "regulatory deficit", wherein national institutions are rendered less effective by the internationalization of markets. 3 A key to understanding the regulatory deficit attendant on the internationalization of markets lies both in an appreciation of the indirect pressures brought to bear on the nation state by deregulated international markets as well as the direct powers of coercion the WTO can now apply to nations to open markets. This paper discusses the potential for the WTO, through its influence on the trade in health and ancillary services, to directly impact publicly funded healthcare delivery systems.
Recent changes in the international trading regime
Most nations are bound by the rules of the General Agreement on Tariff and Trade (GATT), established in 1946 and superseded by the World Trade Organization (WTO) in 1995. The scope of the WTO is much larger than it was under GATT. In the past, trade agreements have largely involved trade in goods such as raw/natural products, manufactured products, and commodities. Today, international agreements have been extended to include trade in intellectual property and services (the fastest growing trade sector among developed nations).
The major impacts on healthcare services in developed nations will likely arise through WTO regulations governing the trade in services.
Potential for trade-in-services regime to impact healthcare delivery
The Trade-Related Intellectual Property Rights (TRIPs) agreement requires all WTO members to adopt US-style patent laws. Over the past several years, the Canadian government, under threat of patent law changes initially introduced via the Free Trade Agreement (FTA) between Canada and the United States, moved to expand patent protection for brand name drug companies at the expense of Canadian generic drug companies that had been supplying the Canadian market with low-cost generic drugs. 4 Although Canada had cracked down on its own generic drug companies, the TRIPs agreement was used to force the Canadian government to extend drug patent protection to multinationals to the full 20 years required under US patent law. 5 The implications for healthcare systems are potentially serious because enhanced patent protection, by allowing drug companies to protect themselves from competition for a longer time, will reduce the availability of cheap drugs. This is a major problem because drugs are the single fastest-growing component of healthcare budgets.
Another important agreement, the General Agreement on Trade in Services (GATS), covers not just cross-border trade, but every possible means of supplying a service. At present, nations have the right to keep sectors of their service economy outside the scope of GATS. However, while Canada has taken the position that its health and education services will not be included in GATS, both the European Union and the United States are in the process of volunteering these sectors for full inclusion under GATS.
Within the United States, diverse stakeholders are trying to force health and education sectors in other nations into full inclusion under GATS. For example, the Coalition of Service Industries is "calling for a major foreign ownership to be allowed for all health facilities. We believe we can make much progress in the negotiations to allow the opportunity for US businesses to expand into foreign health care markets. Historically, health care services in many foreign countries have largely been the responsibility of the public sector. The public ownership of health care has made it difficult for US private-sector health care providers to market in foreign countries." 6 These views are promoted by the US trade delegation at WTO which Depuis le début des années 70, et l'effondrement des accords de Bretton-Woods, les économies s'orientent de plus en plus vers la mondialisation à mesure que les marchés s'internationalisent et se déréglementent, une tendance favorisée par l'Organisation mondiale du Commerce (OMC), grâce à ses moyens nouveaux et sans précédent historique pour faire appliquer les règles du commerce. 1 En quoi est-ce que la mondialisation en général, et l'influence de plus en plus importante de l'OMC en particulier, peuvent intéresser les chercheurs en santé et les décideurs politiques ? Premièrement, « parce qu'en raison des bonnes et des mauvaises conséquences sur la santé des prix de monopole fixés aux nouveaux médicaments et produits médicaux, et à cause de son influence sur le commerce international des fournitures médicales, des assurances, et des services de santé, il est probable que l'Organisation mondiale du Commerce va devenir l'un des plus importants acteurs internationaux en matière de santé. » 2, p. 193 [traduction]
Deuxièmement, en plus des répercus-sions directes de l'OMC sur le commerce des produits médicaux, la mondialisation risque aussi d'influencer la santé en créant un « vide réglementaire », autrement dit l'internationalisation des marchés aboutit à affaiblir l'efficacité des institutions nationales. 3 Pour comprendre le vide régle-mentaire causé par l'internationalisation des marchés, il est essentiel de bien comprendre les pressions indirectes que les marchés déréglementés font peser sur les …voir Éditorial, à la page 18
Le nouvel ordre commercial international : menace pour le système de soins de santé public du Canada ? Such views are also promoted by important American health organizations. The Institute of Medicine in its recent report, America's Vital Interest in Global Health, 8 says that the direct interests of the American people will be served when the United States promotes world health and implies that the process of increased trade in health services will both enhance world health and promote American strategic interests. These kinds of statements in conjunction with recent moves by both the EU and the United States to apply GATS to their own healthcare services, will create external pressure on the Canadian government to do likewise.
Recent moves by the Alberta government -both through contracting out of services to private providers and through the introduction and promotion of Bill C-11 -could also be the trigger for WTO intervention in the Canadian health services delivery market. GATS Article 1.3 states that "the hospital sector in many countries… is made up of governmentowned and privately-owned entities which both operate on a commercial basis, charging the patient or his insurance for the treatment provided." Furthermore, "wherever there is a mixture of public and private funding, such as user charge or private insurance, or there are subsidies for nonpublic infrastructure, such as public/private partnerships or competitive contracting for services, the service sector should be open to foreign competition."
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CONCLUSION
The WTO is emerging as an important player in the trade in health and ancillary services. This is of particular concern for nations like Canada with publicly funded healthcare systems. There are two main areas for potential concern. First, over the past 15 years, as drugs have become the fastest-growing component of healthcare costs, the power of provincial governments to control these costs has been eroded due to restrictive trade and patent rules initially introduced through the FTA agreement and consolidated under the WTO.
Second, the WTO, as well as representatives of the American healthcare industry, have targeted publicly funded healthcare systems -such as Canada's -as a potential market for increased trade in healthcare services. Moves to privatize components of Canada's public system -such as Bill C-11 recently passed in Alberta -provide the WTO with an opening to mount a trade challenge which could allow the entry of the American healthcare industry into Canada.
